CCI Clears Serum Institute Life Sciences-Biocon Biologics Deal
CCI Approves Merger of Covidshield Technologies into Biocon Biologics, Serum Institute Life Sciences Acquires 15% Equity Shareholding The Competition Commission of India (CCI) approves the merger by absorption of Covidshield…
Share